MetaCap

NewcelX Insider Trades

NASDAQ: NCELHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.54-0.15 (-5.58%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $375.00K
Sales
0 · $0
Shares bought / sold
136.36K / 0
Net activity
Net buying $374,998

NewcelX insider activity

Over the last 12 months, NewcelX insiders reported 2 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $374,998 and sold $0 worth of stock, for net insider buying of $374,998. The most recent filing shows Revel Michel (CSO and Director) buying 54,545 shares at $2.75 on Apr 27, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NCEL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NCEL insider transactions

NewcelX insider transactions
DateInsiderTypeSharesValueFiling
Apr 27, 2026Samuel OlivierDirectorBuy81,818$225.00KForm 4
Apr 27, 2026Revel MichelCSO and DirectorBuy54,545$150.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related